Crossmark

Predictors of immune-related adverse events and outcomes in patients with NSCLC treated with immune-checkpoint inhibitors

Crossref DOI link: https://doi.org/10.1016/j.pulmoe.2022.03.003

Published Online: 2025-03-10

Published Print: 2024-07-30

Update policy: https://doi.org/10.1080/tandf_crossmark_01

Authors

Serino, M.

Freitas, C. https://orcid.org/0000-0002-7162-414X
Martins, M. https://orcid.org/0000-0003-2850-2558
Ferreira, P. https://orcid.org/0000-0003-3986-2997
Cardoso, C. https://orcid.org/0000-0002-5483-9317
Veiga, F.

Santos, V.

Araújo, D.

Novais-Bastos, H.

Magalhães, A.

Queiroga, H.

Fernandes, G.

Hespanhol, V.
License Information

Version of Record valid from 2024-07-30
More Information

Peer Review Statement: The publishing and review policy for this title is described in its Aims & Scope.

Aim & Scope: http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=tpul20

Publication History

Received: 2021-10-24

Accepted: 2022-03-14

Published: 2025-03-10